Trinity Biotech PLC
NASDAQ:TRIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kotra Industries Bhd
KLSE:KOTRA
|
MY |
|
Chengdu Hi-tech Development Co Ltd
SZSE:000628
|
CN |
|
Freelance.com SA
PAR:ALFRE
|
FR |
|
H
|
Hibiscus Petroleum Bhd
KLSE:HIBISCS
|
MY |
Trinity Biotech PLC
EPS (Diluted)
Trinity Biotech PLC
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Trinity Biotech PLC
NASDAQ:TRIB
|
EPS (Diluted)
$0
|
CAGR 3-Years
14%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
|
Medtronic PLC
NYSE:MDT
|
EPS (Diluted)
$3
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
STERIS plc
NYSE:STE
|
EPS (Diluted)
$7
|
CAGR 3-Years
N/A
|
CAGR 5-Years
8%
|
CAGR 10-Years
20%
|
|
Trinity Biotech PLC
Glance View
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The company is headquartered in Bray, Wicklow. The firm's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The company operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business.
See Also
What is Trinity Biotech PLC's EPS (Diluted)?
EPS (Diluted)
-0.1
USD
Based on the financial report for Jun 30, 2025, Trinity Biotech PLC's EPS (Diluted) amounts to -0.1 USD.
What is Trinity Biotech PLC's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
42%
Over the last year, the EPS (Diluted) growth was 21%. The average annual EPS (Diluted) growth rates for Trinity Biotech PLC have been 14% over the past three years , 42% over the past five years .
